NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparative effectiveness of radial probe endobronchial ultrasound versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: a randomized pragmatic trial.

Author(s): Steinfort DP, Vincent J, Heinze S, Antippa P, Irving LB

Publication: Respir Med, 2011, Vol. 105, Page 1704-11

PubMed ID: 21875783 PubMed Review Paper? No

Purpose of Paper

This paper compared the diagnostic accuracy and effects of clinical factors on sensitivity of endobronchial ultrasound transbronchial lung biopsies (EBUS-TBLB) and computed tomography-guided percutaneous needle biopsies (CT-PNB) of peripheral pulmonary lesions.

Conclusion of Paper

The diagnostic accuracy was comparable between EBUS-TBLB and CT-PNB (87.5% versus 93.3%), but CT-PNB resulted in a significantly higher rate of complications. Although no clinical factors affected the diagnostic accuracy of CT-PNB, EBUS-TBLB sensitivity was highest when the lesion was located by the probe or when the diagnosis was lung cancer. 

Studies

  1. Study Purpose

    This study compared the diagnostic accuracy of EBUS-TBLB and CT-PNB of peripheral pulmonary lesions and investigated the effects of clinical factors on the sensitivity of each method. A single physician performed all 32 EBUS-TBLB by localization of the lesion by EBUS, replacement of the EBUS probe with a sampling device (forceps or cytology brush), and sampling under fluoroscope. Bronchial washings were collected after EBUS-TBLB.  Sixteen CT-PNB were performed by six different individuals by localization of the lesion using limited CT followed by insertion of the 19-gauge (G) coaxial and 20-G core needle in 15 cases and a 17-G coaxial and 18-G core needle in one case.  Diagnosis included 22 adenocarcinomas, 9 squamous cell lung carcinomas, 3 small cell lung carcinomas, 2 large cell lung carcinomas, 3 non-small cell lung carcinomas, 1 mycobacterium tuberculosis, 1 nodular lymphoid hyperplasia, 1adenosquamous lung carcinoma, 1 chondroid hamartoma, 3 inflammatory masses, and 1 metastatic breast carcinoma. Biopsy fixation and staining methods were not specified.

    Summary of Findings:

    The diagnostic accuracy was comparable between EBUS-TBLB and CT-PNB (87.5% versus 93.3%). No clinical factors affected the diagnostic accuracy of CT-PNB  and EBUS-TBLB was not affected by lesion size, lobar location, and the presence of CT-bronchus sign; but sensitivity of EBUS-TBLB was highest when the lesion was located by the probe (100% versus 50%, P=0.001) or when the diagnosis was lung cancer (24 of 28 versus 1 of 3, P=0.025).. The ability to locate the lesion with the probe during EBUS-TBLB was also associated with a diagnosis of primary lung cancer (19 of 28 versus 0 of 4, P=0.020). Although not significant, a trend to increased sensitivity was observed for lesions located 6 cm or less from the pulmonary hilum (20 of 21 versus 5 of 8 when more than 6 cm). However, CT-PNB resulted in a significantly higher rate of complications than EBUS-TBLB (27% versus 3%, P=0.03).

    Biospecimens
    Preservative Types
    • Other Preservative
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    • Other diagnoses
    • Neoplastic - Benign
    Platform:
    AnalyteTechnology Platform
    Morphology Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of tissue acquisition Ultrasound-guided biopsy
    CT-guided biopsy
    Biospecimen Acquisition Biospecimen location ≤6 cm from pulmonary hilum
    >6 cm from pulmonary hilum
    Preaquisition Prognostic factor ≤2 cm lesion
    >2 cm lesion

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...